Major histocompatibility complex class I expression in human tonsillar and laryngeal epithelium

Clinical and Experimental Immunology

Volumn 145, Issue 2, 2006, Pages 365-371

  Hobbs, C G L ^a,b   Rees, L E N ^a   Heyderman, R S ^a   Birchall, M A ^a   Bailey, M ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b 6 Elmley Lodge ^*  (United Kingdom)

Author keywords

Epithelial cells; Larynx; MHC class I; Tonsil

Indexed keywords

ANTIBODY; BETA 2 MICROGLOBULIN; EPITOPE; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ADOLESCENT; ADULT; ALPHA CHAIN; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOSURVEILLANCE; LAMINA PROPRIA; LARYNGEAL BIOPSY; LARYNX MUCOSA; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SQUAMOUS EPITHELIUM; T LYMPHOCYTE; TONSIL; UPPER RESPIRATORY TRACT;

ADOLESCENT; ADULT; BIOPSY; CROSS-SECTIONAL STUDIES; EPITHELIUM; EPITOPES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LARYNX; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; TONSIL;

EID: 33745958228     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03125.x     Document Type: Article

References (23)

1. IARC Working Group. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 2004; 83:1-1438.
2. IARC Working Group. Alcohol drinking. IARC Working Group, Lyon, 13-20 October 1987. IARC Monogr Eval Carcinog Risks Hum 1988; 44:1-378.
3. IARC Working Group. Epstein-Barr virus and Kaposi's sarcoma herpesvirus/human herpesvirus 8. Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Lyon, France, 17-24 June 1997. IARC Monogr Eval Carcinog Risks Hum 1997; 70:1-492.
4. El Serag HB, Hepworth EJ, Lee P, Sonnenberg A. Gastroesophageal reflux disease is a risk factor for laryngeal and pharyngeal cancer. Am J Gastroenterol 2001; 96:2013-8.
5. Gillison ML, Koch WM, Capone RB et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92:709-20.
6. IARC Working Group. Epstein-Barr virus. IARC Monogr Eval Carcinog Risks Hum 1997; 70:47-373.
7. Rees LE, Ayoub O, Haverson K et al. Differential major histocompatibility complex class II locus expression on human laryngeal epithelium. Clin Exp Immunol 2003; 134:497-502.
8. Rees LE, Gunasekaran S, Sipaul F et al. The isolation and characterisation of primary human laryngeal epithelial cells. Mol Immunol 2006; 43:725-30.
9. + T cell behavior in mucosal and systemic lymphoid tissues during the induction of oral priming and tolerance. J Exp Med 2005; 201:1815-23.
10. Aaltonen LM, Partanen J, Auvinen E et al. HLA-DQ alleles and human papillomavirus DNA in adult-onset laryngeal papillomatosis. J Infect Dis 1999; 179:682-5.
11. Inman CF, Rees LE, Barker E et al. Validation of computer-assisted, pixel-based analysis of multiple-colour immunofluorescence histology. J Immunol Meth 2005; 302:156-67.
12. Daar AS, Fuggle SV, Fabre JW et al. The detailed distribution of HLA-A, B, C antigens in normal human organs. Transplantation 1984; 38:287-92.
13. Fleming KA, McMichael A, Morton JA et al. Distribution of HLA class 1 antigens in normal human tissue and in mammary cancer. J Clin Pathol 1981; 34:779-84.
14. Somnay-Wadgaonkar K, Nusrat A, Kim HS et al. Immunolocalization of CD1d in human intestinal epithelial cells and identification of a beta2-microglobulin-associated form. Int Immunol 1999; 11:383-92.
15. Maleno I, Lopez-Nevot MA, Cabrera T et al. Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21. Cancer Immunol Immunother 2002; 51:389-96.
16. Esteban F, Concha A, Delgado M et al. Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx. Br J Cancer 1990; 62:1047-51.
17. Concha A, Esteban F, Cabrera T et al. Tumour aggressiveness and MHC class I and II antigens in laryngeal and breast cancer. Semin Cancer Biol 1991; 2:47-54.
18. Stanley M. The immunology of genital human papilloma virus infection. Eur J Dermatol 1998; 8:8-12.
19. Vambutas A, Bonagura VR, Steinberg BM. Altered expression of TAP-1 and major histocompatibility complex class I in laryngeal papillomatosis: correlation of TAP-1 with disease. Clin Diagn Lab Immunol 2000; 7:79-85.
20. Ashrafi GH, Haghshenas MR, Marchetti B et al. E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I. Int J Cancer 2005; 113:276-83.
21. Birchall M, Bailey D, King P. Effect of process standards on survival of patients with head and neck cancer in the south and west of England. Br J Cancer 2004; 91:1477-81.
22. Eura M, Katsura F, Oiso M et al. Frequency of HLA-A alleles in Japanese patients with head and neck cancer. Jpn J Clin Oncol 1999; 29:535-40.
23. Foulkes WD, Brunet JS, Sieh W et al. Familial risks of squamous cell carcinoma of the head and neck: retrospective case-control study. BMJ 1996; 313:716-21.